A comparison of the effect of total intravenous anaesthesia with propofol and remifentanil and inhalational anaesthesia with isoflurane on the release of pro- and anti-inflammatory cytokines in patients undergoing open cholecystectomy

Anaesthesia and Intensive Care

Volumn 36, Issue 1, 2008, Pages 74-78

  Ke, J J ^a   Zhan, J ^a   Feng, X B ^a   Wu, Y ^a   Rao, Y ^a   Wang, Yan Lin ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Interleukin 10; Interleukin 6; Propofol; Remifentanil; Total intravenous anaesthesia; Tumour necrosis factor

Indexed keywords

CYTOKINE; FENTANYL; INTERLEUKIN 10; INTERLEUKIN 6; ISOFLURANE; PROPOFOL; REMIFENTANIL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD TRANSFUSION; CHOLECYSTECTOMY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; INHALATION ANESTHESIA; INTRAVENOUS ANESTHESIA; MALE; POSTOPERATIVE PERIOD; PROTEIN BLOOD LEVEL;

EID: 38949186743     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0803600113     Document Type: Article

References (31)

1. Blackburn S. Surgical stress. J Perinat Neonatal Nurs 2007; 21:9-10.
2. Desborough JP. The stress response to trauma and surgery. Br J Anaesth 2000; 85:109-117.
3. Ni Choileain N, Redmond HP. Cell response to surgery. Arch Surg 2006; 141:1132-1140.
4. Dimopoulou I, Armaganidis A, Douka E, Mavrou I, Augustatou C, Kopterides P et al. Tumour necrosis factor-alpha (TNFalpha) and interleukin-10 are crucial mediators in post-operative systemic inflammatory response and determine the occurrence of complications after major abdominal surgery. Cytokine 2007; 37:55-61.
5. Jawa RS, Kulaylat MN, Baumann H, Dayton MT. What is new in cytokine research related to trauma/critical care. J Intensive Care Med 2006; 21:63-85.
6. Schneemilch CE, Schilling T, Bank U. Effects of general anaesthesia on inflammation. Best Pract Res Clin Anaesthesiol 2004; 18:493-507.
7. Kelbel I, Weiss M. Anaesthetics and immune function. Curr Opin Anaesthesiol 2001; 14:685-691.
8. Homburger JA, Meiler SE. Anesthesia drugs, immunity, and long-term outcome. Curr Opin Anaesthesiol 2006; 19:423-428.
9. Bellomo R. The cytokine network in the critically ill. Anaesth Intensive Care 1992; 20:288-302.
10. Cutler A, Brombacher F. Cytokine therapy. Ann N Y Acad Sci 2005; 1056:16-29.
11. Norman JG, Fink GW. The effects of epidural anesthesia on the neuroendocrine response to major surgical stress: a randomized prospective trial. Am Surg 1997; 63:75-80.
12. Hildebrand F, Pape HC, Hoevel P, Krettek C, van Griensven M. The importance of systemic cytokines in the pathogenesis of polymicrobial sepsis and dehydroepiandrosterone treatment in a rodent model. Shock 2003; 20:338-346.
13. Cavaillon JM, Annane D. Compartmentalization of the inflammatory response in sepsis and SIRS. J Endotoxin Res 2006; 12:151-170.
14. Moller B, Villiger PM. Inhibition of IL-1, IL-6, and TNF-alpha in immune-mediated inflammatory diseases. Springer Semin Immunopathol 2006; 27:391-408.
15. Zanotti S, Kumar A, Kumar A. Cytokine modulation in sepsis and septic shock. Expert Opin Investig Drugs 2002; 11:1061-1075.
16. Naka T, Nishimoto N, Kishimoto T. The paradigm of IL-6: from basic science to medicine. Arthritis Res 2002; 4:233-242.
17. Nishimoto N, Kishimoto T. Inhibition of IL-6 for the treatment of inflammatory diseases. Curr Opin Pharmacol 2004; 4:386-391.
18. Kamimura D, Ishihara K, Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol 2003; 149:1-38.
19. Ishihara K, Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev 2002; 13:357-368.
20. Hogevold HE, Lyberg T, Kahler H, Haug E, Reikeras O. Changes in plasma IL-1beta, TNF-alpha and IL-6 after total hip replacement surgery in general or regional anaesthesia. Cytokine 2000; 12:1156-1159.
21. Wittke F, Hoffmann R, Buer J, Dallmann I, Oevermann K, Sel S et al. Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma. Br J Cancer 1999; 79:1182-1184.
22. Conti P, Kempuraj D, Kandere K, Di Gioacchino M, Barbacane RC, Castellani ML et al. IL-10, an inflammatory/inhibitory cytokine, but not always. Immunol Lett 2003; 86:123-129.
23. Lang R, Patel D, Morris JJ, Rutschman RL, Murray PJ. Shaping gene expression in activated and resting primary macrophages by IL-10. J Immunol 2002; 169:2253-2263.
24. Lin E, Calvano SE, Lowry SF. Inflammatory cytokines and cell response in surgery. Surgery 2000; 127:117-126.
25. Hildebrand F, Pape HC, Krettek C. The importance of cytokines in the posttraumatic inflammatory reaction. Unfallchirurg 2005; 108:793-794,796-803.
26. Chang Y, Chen TL, Sheu JR, Chen RM. Suppressive effects of ketamine on macrophage functions. Toxicol Appl Pharmacol 2005; 204:27-35.
27. Larsen B, Hoff G, Wilhelm W, Buchinger H, Wanner GA, Bauer M. Effect of intravenous anesthetics on spontaneous and endotoxin-stimulated cytokine response in cultured human whole blood. Anesthesiology 1998; 89:1218-1227.
28. Cohen J, Royston D. Remifentanil. Curr Opin Crit Care 2001; 7:227-231.
29. Lison S, Schill M, Conzen P. Fast-track cardiac anesthesia: efficacy and safety of remifentanil versus sufentanil. J Cardiothorac Vasc Anesth 2007; 21:35-40.
30. Crozier TA, Müller JE, Quittkat D, Sydow M, Wuttke W, Kettler D. Effect of anaesthesia on the cytokine responses to abdominal surgery. Br J Anaesth 1994; 72:280-285.
31. van den Bergh P, Dobber R, Ramlal S, Rozing J, Nagelkerken L. Role of opioid peptides in the regulation of cytokine production by murine CD4+ T cells. Cell Immunol 1994; 154:109-122.